Global High-Priority Regulatory Events — February 26, 2026

27-02-2026

Lesaka Technologies' Remuneration Committee increased Lincoln Mali's annual base salary to ZAR 8,000,000 ($503,176) effective February 1, 2026, and awarded him a one-off bonus of ZAR 3,500,000 ($220,140). The Committee also adopted fiscal 2026 cash incentive awards for executives Steven Heilbron (base $400,000, max $480,000), Lincoln Mali (max ZAR 9,600,000 or $603,812), and Dan Smith (base ZAR 6,750,000, max ZAR 8,100,000 or $509,466), with payouts ranging from 20% to 120% of base salary based on quantitative (30-50% weighting) and qualitative performance factors. No prior period compensation data is provided for comparison.

• ·Quantitative targets include Group Net Revenue (10% allocation for all), Group Adjusted EBITDA (10%), Positive Earnings (10%), with additional targets for Dan Smith (Net Debt:EBITDA 10%, Free Cash Flow Conversion 10%) and Lincoln Mali (Consumer Segment Adj. EBITDA 10%).
• ·Qualitative criteria for Steven Heilbron include M&A objectives (45% of qualitative), Bank Zero integration (15%), and corporate culture (10%).
• ·Exchange rate used: $1 = ZAR 15.8990 as of February 26, 2026.
• ·Remuneration Committee has discretion to adjust awards from 0% to maximum, including to zero.

27-02-2026

Applied Optoelectronics, Inc. (AAOI) entered into a Texas Net Lease agreement dated February 10, 2026, with Blue Ridge Commerce Center West LLC for 153,928 rentable square feet of premises (Building #3) at Blue Ridge Commerce Center, 16851 Blue Ridge Commerce Dr., Houston, TX, representing 100% of the building and 11.40% of the project. The 130-month lease term commences on or around February 10, 2026, with 5 months of base rent abatement followed by escalating monthly base rent from $66,189 ($0.43/RSF) in months 6-10 to $186,732 ($1.21/RSF) in months 121-130, initial estimated monthly operating expenses of $30,786, prepaid rent of $163,164 applied to month 11, and a $2M security deposit. The premises will be used for general distribution, office, warehouse, and light manufacturing/assembly of PCBs, PCBA, and semiconductors.

• ·Commencement Date: Earlier of Tenant occupancy for business or February 10, 2026
• ·Effective Date: February 10, 2026
• ·Tenant Notice Address (pre-Commencement): 13139 Jess Pirtle, Sugar Land, TX 77478
• ·Landlord Notice Address: c/o George R. Farish II, Trammell Crow Company, 2800 Post Oak Blvd., Suite 400, Houston, TX 77056

27-02-2026

IQM Finland Oy and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a SPAC, entered a definitive business combination agreement on February 23, 2026, to take IQM public via American Depositary Shares on a leading U.S. stock exchange, with potential dual listing on Helsinki; the deal aims to fund IQM's advancement toward fault-tolerant quantum computing. IQM, a leader in full-stack superconducting quantum computers with over 300 employees and global presence, and RAAQ will host a conference call/webcast to discuss transaction highlights, with recording available at https://meetiqm.com/investors/. No financial metrics or historical performance data provided; forward-looking statements note significant risks including technical challenges, net losses, and potential redemptions.

• ·Agreement announced February 23, 2026; press release dated February 27, 2026.
• ·IQM headquartered in Finland with presence in France, Germany, Italy, Japan, Poland, Saudi Arabia, Spain, Singapore, South Korea, Taiwan, UK, US.
• ·RAAQ based in Princeton, NJ; IPO prospectus filed April 30, 2025.
• ·Upcoming SEC Form F-4 registration statement including proxy statement/prospectus.

27-02-2026

27-02-2026

27-02-2026

27-02-2026

27-02-2026

27-02-2026

27-02-2026

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) announced a proposed private placement of $200M aggregate principal amount of Convertible Senior Notes due 2032 to qualified institutional buyers under Rule 144A, with an option for initial purchasers to buy up to an additional $30M within 13 days of issuance. Net proceeds will fund capped call transactions to offset potential dilution and general corporate purposes, including acquisitions, strategic investments, working capital, and capital expenditures. The offering is subject to market conditions, with terms like interest rate and conversion rate to be set at pricing; forward-looking statements highlight risks such as market changes and failure to close.

• ·Notes are general unsecured obligations accruing semiannual interest; conversion at Tandem's election into cash, shares, or combination.
• ·Capped call transactions with option counterparties to cover shares underlying the notes, subject to cap.
• ·Notes and conversion shares unregistered under Securities Act; no offer/sale without exemption.
• ·Announcement date: February 23, 2026; SEC filing date: February 27, 2026.
• ·Maturity: 2032; hedge modifications possible by counterparties through maturity.

27-02-2026

27-02-2026

Alan S. Roemer resigned as a director of IN8bio, Inc. and as a member of the Audit and Compensation Committees, effective February 28, 2026, with no disagreements cited regarding the company's operations, policies, or practices. The Board appointed independent director Jeremy Graff as Interim Chair of the Board, effective the same date.

27-02-2026

On February 26, 2026, the Compensation Committee of Iridium Communications Inc. approved the Annual Performance Bonus Plan, making eligible employees including CEO, CFO, and other NEOs eligible for cash or RSU bonuses up to 200% of target based on corporate and individual performance goals for periods starting January 1, 2026. The Committee also adopted the Executive Severance Plan, providing non-CIC severance of 18 months base salary (CEO) or 12 months (other NEOs) plus prorated bonus and COBRA, with enhanced CIC benefits including 2X (CEO) or 1.5X (others) of base plus target bonus and full equity vesting acceleration. These plans are subject to recoupment under the Company's Incentive Compensation Recoupment Policy and will be filed as exhibits to the Q1 2026 10-Q.

• ·Non-CIC severance includes prorated annual target bonus and COBRA premiums for up to 12 months.
• ·CIC severance paid in lump sum with full acceleration of outstanding equity awards.
• ·Plans require execution of waiver/release and compliance with restrictive covenants.

27-02-2026

Mitesco, Inc. disclosed via 8-K the execution of a Senior Secured Original Issue Discount Convertible Promissory Note by its subsidiary Amaze Holdings, Inc. to C/M Capital Master Fund, LP, pursuant to a Securities Purchase Agreement, with maturity 18 months from issuance and no interest accruing absent default. The note is secured by a first-priority lien on assets via a Security Agreement and fully guaranteed by subsidiaries, ranking senior to other indebtedness except pari passu with other notes issued under the same agreement. Events of default include payment failures, breaches, bankruptcy, and judgments exceeding $50,000, triggering 10% default interest.

• ·Maturity Date: 18 months from Original Issuance Date
• ·No interest accrues unless Event of Default (then 10% p.a., compounding monthly on 360-day year)
• ·Holder participation right in subsequent financings up to 100% Pro Rata Portion at 10% discount
• ·Cure periods: 10 days for certain breaches
• ·Proceedings undismissed for 45 or 30 days trigger default
• ·Hypothetical exchange example: $100,000 Note portion for Common Stock at 20% effective discount ($4.00 vs $5.00/share)

27-02-2026

Western New England Bancorp, Inc. announced on February 24, 2026, that Paul Picknelly, a member of its Board of Directors, will retire effective May 14, 2026, immediately following the 2026 Annual Meeting of Stockholders. Mr. Picknelly's decision was not due to any disagreement with the company's operations, policies, or practices. No other changes or financial impacts were disclosed.

27-02-2026

Tennant Company (TNC) announced on February 26, 2026, that Barb Balinski, age 62 and Senior Vice President, Chief Transformation Officer, gave notice of her intention to retire effective September 3, 2026. The filing was made on February 27, 2026, under Item 5.02. No immediate successor or additional details on transition plans were disclosed.

• ·Company headquarters: 10400 Clean Street, Eden Prairie, Minnesota 55344-2650
• ·Common Stock: par value $0.375 per share, traded as TNC on NYSE

27-02-2026

Comcast Corporation's Board of Directors appointed Gordon Smith to the Audit Committee on February 25, 2026, following his prior appointment as a director on February 4, 2026. This governance update was reported in an 8-K filing on February 27, 2026, under Item 5.02. No financial impacts or other changes were disclosed.

27-02-2026

Wyndham Hotels & Resorts, Inc. entered into a Seventh Supplemental Indenture on February 27, 2026, to issue $650M aggregate principal amount of 5.625% senior notes due 2033. Net proceeds were used to repay all outstanding borrowings under its term loan A and revolving credit facility, related fees, and for general corporate purposes. The notes are senior unsecured obligations, equal in right of payment to existing senior debt like the 4.375% notes due 2028, and guaranteed by certain domestic subsidiaries.

• ·Interest payable semi-annually in arrears on March 1 and September 1, commencing September 1, 2026.
• ·Optional redemption prior to March 1, 2029 at make-whole price or up to 40% of principal with equity offering proceeds; thereafter at 102.813% (2029), 101.406% (2030), and 100.000% (2031+).
• ·Change of Control Triggering Event requires repurchase offer at 101% of principal.
• ·Covenants restrict incurrence of liens-secured debt and sale-leaseback transactions.
• ·Notes effectively subordinated to secured credit facilities and structurally to non-guarantor subsidiaries' obligations.

27-02-2026

On February 24, 2026, Hadar Levy, a Class I director on the Board of Directors of Lifeward Ltd., notified the company of his decision to step down from the Board, effective immediately. His departure did not result from any disagreement with the company's operations, policies, or practices. The company expressed gratitude for his distinguished service and contributions.

• ·Filing date: February 27, 2026
• ·Company address: 2 Cabot Rd., Hudson, MA 01749
• ·Trading symbol: LFWD (Nasdaq Capital Market)

27-02-2026

Algorhythm Holdings, Inc. entered into an Amended and Restated Employment Agreement with Gary Atkinson as Chief Executive Officer, effective February 23, 2026, for an initial three-year term automatically renewable annually unless 90 days' notice is given. Compensation includes a $360K annual base salary, eligibility for up to 50% ($180K) annual bonus (half guaranteed if employed full year, half tied to capital raise and $10M revenue target for FY2026), and a stock option for approximately 5% of fully diluted common shares vesting quarterly over four years. Additional terms include a change-in-control bonus of up to $540K, standard benefits, and a requirement to spend an average of two days per week in the Fort Lauderdale office.

• ·Stock option exercise price equals closing price of common stock on Nasdaq on Effective Date (February 23, 2026).
• ·Agreement supersedes conflicting terms in 2022 Equity Incentive Plan or stock option grant notice.
• ·Executive permitted to maintain prior consulting arrangement with Stingray Music USA, Inc. approved by Board.
• ·Termination requires 30 days' advance written notice unless for Cause.
• ·Company to register shares underlying stock option via amendment to Form S-8 (File No. 333-268106) or new filing by first anniversary of Effective Date.

27-02-2026

On February 26, 2026, Jupiter Neurosciences, Inc. received Nasdaq notices for non-compliance with the Minimum Bid Price Requirement (closing bid price < $1.00 for 30 consecutive business days from January 13 to February 25, 2026) and the MVLS Requirement (market value of listed securities below $35M for the same period), both critical for continued listing on Nasdaq Capital Market. However, the Company has 180 calendar days until August 25, 2026, to regain compliance by meeting $1.00 bid for 10+ consecutive business days and $35M MVLS for 10 consecutive days, with trading continuing uninterrupted under ticker JUNS. The Company plans to monitor and may pursue options like a reverse stock split, though success is uncertain.

• ·Nasdaq may require bid price maintenance beyond 10 days, up to 20 consecutive business days.
• ·Eligibility for second 180-day compliance period requires meeting MVLS and other initial listing standards (except bid price) and notifying intent to cure, potentially via reverse stock split.
• ·Designated disclosure channels: website https://jupiterneurosciences.com, X @jupiterneuro, Instagram @Nugevia.
• ·Address: 1001 North US HWY 1, Suite 504, Jupiter, FL 33477; Phone: (561) 406-6154.

27-02-2026

AIR Industries Group filed an 8-K on February 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement's terms, parties, value, financial impact, or any quantitative metrics are provided.

27-02-2026

Miluna Acquisition Corp entered into an Indemnification Agreement with Yajuan Ding on February 25, 2026, to indemnify him against liabilities arising from his service as a director or officer, including expenses, judgments, and settlements, subject to exceptions for willful neglect, default, or fraud. The agreement provides for advancement of expenses within 30 days of request and detailed procedures for determining indemnification entitlement. No financial metrics or performance data are disclosed.

27-02-2026

Datavault AI Inc. filed an 8-K on February 27, 2026 (AccNo: 0001104659-26-020936), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or operational details were disclosed. This represents a material negative development with no mentioned positives or offsets.

27-02-2026

Limitless X Holdings Inc. filed a Form 8-K on February 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific details such as transaction value, parties, terms, financial metrics, or impacts are disclosed.

27-02-2026

Ultra Clean Holdings, Inc. filed a Form 8-K on February 27, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, events, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no period-over-period comparisons, guidance, or named entities beyond the filer provided.

27-02-2026

Ginkgo Bioworks Holdings, Inc. filed an 8-K on 2026-02-27 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed.

27-02-2026

FrontView REIT, Inc. filed a Form 8-K on February 27, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, share counts, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

27-02-2026

Abony Acquisition Corp. I filed an 8-K on 2026-02-27 disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on merger or acquisition structure, parties, valuation, synergies, or impacts are provided in the filing summary. Sector is not specified, and no quantitative metrics, comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-021014
• ·Filing size: 422 KB

27-02-2026

Matador Resources Co filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. No quantitative metrics, positive or negative changes, or financial impacts are disclosed.

• ·Filing Accession Number: 0001104659-26-020877
• ·Filing Size: 500 KB
• ·Sector: NOT_DISCLOSED

27-02-2026

Graphic Packaging Holding Co filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, size, parties, or financial impacts provided in the available information. No quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are mentioned.

27-02-2026

27-02-2026

Larimar Therapeutics, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or strategic context are mentioned.

27-02-2026

27-02-2026

Trimas Corp filed an 8-K on 2026-02-27 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors/officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

27-02-2026

27-02-2026

27-02-2026

Tasty Dairy Specialities Ltd (BSE:540955) has been granted an extension in its Corporate Insolvency Resolution Process (CIRP) for the submission of Resolution Plans from 28.02.2026 to 07.03.2026. This update indicates the process is ongoing without immediate liquidation, but no details on creditors, financial position, or resolution bids are disclosed. The filing provides no quantitative financial metrics, creditor information, or prior timelines for comparison.

• ·CIRP stage: Resolution plan submission phase (pre-approval)
• ·No details on default amount, creditors, or company financials

27-02-2026

On February 25, 2026, DNOW Inc. Board member Rodney Eads notified the company of his intention not to stand for reelection at the 2026 annual meeting of stockholders, with his term expiring on the meeting date. The departure is not due to any disagreement with the company's operations, policies, or practices. The Board thanked Mr. Eads for his service.

• ·Company headquartered at 7402 North Eldridge Parkway, Houston, Texas 77041
• ·Common Stock traded on NYSE under ticker DNOW

27-02-2026

27-02-2026

Smurfit Westrock plc filed an 8-K on 2026-02-27 disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key positions affected, individuals involved, reasons for change, appointment or resignation type, timing, or compensatory terms are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

27-02-2026

27-02-2026

27-02-2026

27-02-2026

Roman DBDR Acquisition Corp. II filed an 8-K on 2026-02-27 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event. The filing also includes Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific deal terms, financial metrics, parties involved, or quantitative details are disclosed.

27-02-2026

TechTarget, Inc. filed an 8-K on February 27, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including key positions affected, names, appointment or resignation status, reasons, timing, and any quantitative data are NOT_DISCLOSED.

27-02-2026

Alight, Inc. filed an 8-K on February 27, 2026 (AccNo: 0001193125-26-079261), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

27-02-2026

KORE Group Holdings, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, transaction value, financial metrics, or impacts are disclosed in the provided filing summary. All quantitative data, parties involved, and outcomes remain NOT_DISCLOSED.

27-02-2026

MBX Biosciences, Inc. filed an 8-K on February 27, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, transaction sizes, personnel names, or financial impacts are provided in the filing summary.

27-02-2026

DUOS Technologies Group, Inc. filed an 8-K on February 27, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, names, reasons for changes, financial metrics, or performance impacts are disclosed.

27-02-2026

Amazon.com Inc filed an 8-K on February 27, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with the core event being a material definitive agreement, though specific details, transaction value, parties, and impacts are NOT_DISCLOSED. No financial metrics, guidance changes, or quantitative impacts are provided in the filing summary.

27-02-2026

Enzon Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-27 reporting entry into a material definitive agreement under Item 1.01 (potential strategic positive) but also material modifications to rights of security holders under Item 3.03 (potential negative for shareholders), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed. No positive or negative quantitative changes are mentioned.

27-02-2026

Nucor Corp filed an 8-K on February 27, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed.

27-02-2026

Avidity Biosciences, Inc. filed an 8-K on February 27, 2026, disclosing the termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). These items collectively indicate a completed significant corporate transaction involving change of control and delisting, with no financial metrics, deal values, or performance comparisons provided. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

27-02-2026

Albertsons Companies, Inc. filed an 8-K on 2026-02-27 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or quantitative data are disclosed.

27-02-2026

reAlpha Tech Corp. filed an 8-K on 2026-02-27 disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule under Item 3.01, alongside Departure of Directors or Certain Officers under Item 5.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing signals a major negative development with delisting, which typically impairs liquidity and investor access, compounded by potential leadership changes. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

27-02-2026

FG Nexus Inc. filed an 8-K on February 27, 2026, disclosing material modifications to rights of security holders under Item 3.03 and amendments to articles of incorporation or bylaws (or change in fiscal year) under Item 5.03. Item 9.01 references financial statements and exhibits. No specific details, financial impacts, or quantitative metrics on these changes are disclosed in the provided information.

27-02-2026

Dynex Capital Inc filed an 8-K on February 27, 2026 (AccNo: 0001104659-26-021080), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Event date: February 27, 2026
• ·Filing size: 264 KB
• ·Sector: NOT_DISCLOSED

27-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-27 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 8.01 reports other events, and Item 9.01 includes financial statements and exhibits. No financial metrics, transaction values, or period-over-period comparisons are disclosed.

• ·Multi-item 8-K filing (Items 3.01, 8.01, 9.01)
• ·Filed on 2026-02-27 with AccNo: 0001213900-26-021116

27-02-2026

GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES filed an 8-K on February 27, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed. No positive or negative metrics are mentioned.

27-02-2026

Ohio Valley Banc Corp filed an 8-K on February 27, 2026 (AccNo: 0000894671-26-000021, Size: 149 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for change, and any governance or financial impacts are NOT_DISCLOSED. No quantitative metrics, scheduled events, or other financial data are mentioned in the provided filing information.

27-02-2026

BancFirst Corp (/OK/) filed an 8-K on 2026-02-27 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. Specific details including the key position affected, whether it is an appointment or resignation, internal/external status, reason, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

27-02-2026

Presurance Holdings, Inc. closed its Rights Offering on February 27, 2026, issuing 4,284,640 shares of common stock upon exercise of subscription rights at $1.00 per share and an additional 9,715,360 shares to Clarkston Companies, Inc. under the backstop commitment. The company received $14M in gross proceeds, which are being used to redeem its Series B Preferred Stock including all accrued dividends, and for general corporate purposes. Unexercised rights expired on February 24, 2026, with no negative impacts reported.

• ·Backstop Agreement dated February 3, 2026
• ·Previous 8-K filed January 28, 2026
• ·S-1 registration (File No. 333-292735) effective February 6, 2026
• ·Subscription deadline: 5:00 p.m. ET on February 24, 2026

27-02-2026

On February 25, 2026, Myrna M. Soto informed the Board of Directors of Popular, Inc. that she will not stand for re-election upon the expiration of her current term at the 2026 Annual Meeting of Shareholders, scheduled for May 8, 2026. Her decision to retire does not result from any disagreement with the Corporation on operations, policies, or practices. In connection with her retirement, the Board will reduce its size from twelve to eleven directors, effective at the Annual Meeting.

• ·Event reported on February 25, 2026; filing dated February 27, 2026.
• ·Principal executive offices: 209 Muñoz Rivera Avenue, Hato Rey, Puerto Rico 00918.

27-02-2026

Sphere 3D Corp. (NASDAQ: ANY) received notice from Nasdaq on February 26, 2026, confirming it has regained compliance with Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. This resolves the deficiency initially notified on March 6, 2025. No further actions or ongoing issues related to this rule are mentioned.

• ·Registrant's principal executive offices: 243 Tresser Blvd, 17th Floor, Stamford, Connecticut, United States 06901
• ·Telephone number: (647) 952 5049
• ·IRS Employer Identification No.: 98-1220792
• ·Commission File Number: 001-36532

27-02-2026

Netflix, Inc. announced the termination of its Amended and Restated Agreement and Plan of Merger with Warner Bros. Discovery, Inc. (WBD) on February 27, 2026, following WBD's acceptance of a superior proposal from Paramount Skydance Corporation (PSKY), ending Netflix's planned acquisition of WBD's Streaming & Studios businesses. Netflix received a $2.8B termination fee paid by PSKY on behalf of WBD, providing a financial offset to the lost deal. Related financing commitments, including bridge debt, incremental commitments, revolving credit facility, and delayed draw term loan, were automatically terminated.

• ·Merger Agreement originally amended on January 19, 2026; termination notices exchanged February 26, 2026.
• ·Related financing: Debt Commitment Letter (Dec 4, 2025), Incremental Commitments Agreement (Jan 19, 2026), 2025 RCF (Dec 19, 2025), DDTL Credit Agreement (Dec 19, 2025) all terminated.

27-02-2026

Fold Holdings, Inc. (NASDAQ: FLD) announced the extinguishment of $66.3 million in convertible note obligations through strategic capital transactions, simplifying its capital structure by eliminating all convertible notes and their restrictive covenants. The company released 521 bitcoin from collateral and reduced potential share dilution by an estimated 8.0 to 10.0 million shares. This positions Fold for growth, including the launch of the Fold Credit Card and expansion into enterprise services.

• ·Transactions restore operational and financing flexibility by removing consent requirements and execution friction from prior notes.
• ·Bitcoin treasury can now support operational expenses, credit card warehouse/reserve requirements, or future financing.

27-02-2026

Indaptus Therapeutics, Inc. amended its Amended and Restated Certificate of Incorporation, effective February 27, 2026, to increase authorized capital stock to 1 billion shares of common stock ($0.01 par value) and 5 million shares of undesignated preferred stock ($0.01 par value). The amendment also permits stockholder actions by written consent without a meeting, subject to preferred stock rights, as approved by stockholders. No financial impacts or operational changes are disclosed.

• ·Original incorporation date: February 24, 2021
• ·Amendment adopted per Section 242 of Delaware General Corporation Law

27-02-2026

CIMG Inc. announced on February 27, 2026, that it received a letter from Nasdaq on February 23, 2026, stating the Nasdaq Hearings Panel will consider the company's failure to timely file its Form 10-Q for the period ended December 31, 2025, as an additional basis for potential delisting under Nasdaq Listing Rule 5250(c)(1) during the monitor period. The company is working diligently to complete and file the overdue 10-Q, with no immediate impact on the trading of its common stock under the symbol 'IMG' on The Nasdaq Capital Market. This development heightens delisting risks amid ongoing compliance issues.

• ·Company website: http://www.ccmg.tech
• ·IR contact: ir@ccmg.tech, +852 70106695

27-02-2026

Birchtech Corp. priced an underwritten public offering of 6,250,000 shares at $2.40 per share for gross proceeds of $15M, with a 30-day underwriter option for up to 937,500 additional shares; the offering is expected to close on or about February 27, 2026. Concurrently, the company's common stock was approved for listing on NYSE American, beginning trading under symbol BCHT on February 26, 2026, terminating OTCQB trading while remaining on TSX. Net proceeds, combined with existing cash, will support operating expenses, working capital, and general corporate purposes.

• ·Registration statement on Form S-1 (File No. 333-292701) became effective on February 17, 2026.
• ·Offering managed by joint book-running managers Lake Street Capital Markets, LLC and Huntington Securities, Inc.

27-02-2026

Aviat Networks, Inc. entered into Amendment No. 2 to its Amended and Restated Tax Benefit Preservation Plan with Computershare Inc. on February 27, 2026, extending the plan's final expiration date to March 3, 2029, subject to stockholder ratification at the 2026 annual meeting. The amendment protects the company's Tax Benefits, including net operating losses, which the Board views as valuable assets. If not approved, the plan will terminate upon certification of the voting results.

• ·Original Plan dated August 27, 2020; previously amended February 28, 2023
• ·Filing incorporates Exhibit 4.1: Amendment No. 2

27-02-2026

Northpointe Bancshares, Inc. (NYSE: NPB) announced the appointment of Rodney E. Hood, former Acting Comptroller of the Currency and Chairman of the National Credit Union Administration (NCUA), to the Board of Directors of the Company and its subsidiary Northpointe Bank, effective February 27, 2026. Hood brings nearly three decades of financial services leadership, including roles at the FDIC, FSOC, and FFIEC, to support strategic growth, governance, and risk management. Chairman and CEO Chuck Williams highlighted Hood's expertise in innovation and community value, aligning with the company's focus as a leading mortgage warehouse financing provider.

• ·Headquartered in Grand Rapids, Michigan.
• ·Contacts: Kevin Comps (616-974-8491), Brad Howes (616-726-2585).

27-02-2026

Lisata Therapeutics, Inc. and Kuva Labs Inc. executed an Amendment to their Binding Term Sheet, effective February 27, 2026, extending the term of the original agreement dated January 20, 2026, from February 28, 2026, to March 7, 2026. No other terms of the Term Sheet were modified, and it remains in full force and effect.

• ·Amendment executed in counterparts.
• ·Original Term Sheet dated January 20, 2026.

27-02-2026

IMAC Holdings, Inc. entered into a secured promissory note on February 26, 2026, with a principal amount of $175,000 issued for a purchase price of $125,000, representing a steep 28.6% discount indicative of distressed financing. The note matures upon written demand by the lender and includes standard events of default such as bankruptcy, with no prepayment penalties. No other financial metrics or performance comparisons were disclosed.

• ·Note is secured and includes customary representations, warranties, covenants, and events of default.
• ·Maturity date: upon holder's written demand.

27-02-2026

PRIMEENERGY RESOURCES CORPORATION entered into the Fifth Amendment to its Fourth Amended and Restated Credit Agreement effective February 24, 2026, reaffirming the Borrowing Base at $115M, providing continued liquidity at stable levels. However, the amendment increases Applicable Margins across the Borrowing Base Utilization Grid (e.g., 2.75% SOFR and 1.75% ABR for <25% utilization, up to 3.75% SOFR and 2.75% ABR for >90%), raising borrowing costs, and sets Term SOFR Adjustment to 0.0%. Certain covenant thresholds in Section 8.20 were relaxed from 25% to 30%, while post-closing obligations require mortgages covering 90% of Borrowing Base Value and title information on 85% within 45 days.

• ·Amendment serves as Scheduled Redetermination for December 1, 2025.
• ·Post-closing delivery of Mortgages/Mortgage amendments and title information due within 45 days of February 24, 2026.
• ·Lender Applicable Percentages: Citibank and Fifth Third Bank at 26.521739130% each; others at 15.652173913% each.

27-02-2026

On February 25, 2026, American Tower Corporation's Compensation Committee approved 2026 base salaries and target cash bonus potentials for its named executive officers, including CEO Steven O. Vondran at $1,000,000 base and $2,000,000 target (200% of base), and other executives with bases from $605,000 to $706,200 and 125% targets. Former EVP Olivier Puech retired effective January 2, 2026, and is excluded from the 2026 compensation determinations. Bonuses will be based on company financial goals and individual performance, with potential upside to 200% of target.

• ·Compensation Committee decisions based on pre-established company financial goals and individual objectives, with potential bonus increase up to 200% of target if goals exceeded.
• ·Additional compensation details to be in 2026 Proxy Statement.
• ·Olivier Puech retirement effective January 2, 2026.

27-02-2026

On February 25, 2026, PennantPark Floating Rate Capital Ltd. entered into an underwriting agreement with Raymond James & Associates, Inc., as representative of the several underwriters, and PennantPark Investment Advisers, LLC, for the issuance and sale of $200 million aggregate principal amount of 6.75% Notes due 2029. The offering is made pursuant to the company's effective shelf registration statement on Form N-2 (Registration No. 333-279726), supplemented by prospectuses dated February 25, 2026. No period-over-period financial comparisons are provided in the filing.

• ·Underwriting Agreement filed as Exhibit 1.1
• ·Shelf registration statement: Form N-2 (Registration No. 333-279726)
• ·Preliminary prospectus supplement and final prospectus supplement both dated February 25, 2026

27-02-2026

Advanced Drainage Systems, Inc. entered into a Fourth Amendment to its Credit Agreement on February 27, 2026, refinancing in full its existing term loans with new 2026 Refinancing Term Loans equal to the outstanding principal and replacing existing revolving commitments with new 2026 Refinancing Revolving Commitments plus incremental commitments to achieve a total revolving facility of $750M. The amendment also includes $192M in new 2026 Incremental Term Loans and replaces Barclays Bank PLC with PNC Bank, National Association as administrative agent. No performance declines noted, but the transactions increase overall debt capacity.

• ·Refinancing matches aggregate principal of existing term loans and revolving commitments outstanding prior to amendment.
• ·Bank of America, N.A. designated as Term Administrative Agent.
• ·PNC Capital Markets LLC, Bank of America, N.A., and others act as joint lead arrangers and bookrunners.

27-02-2026

Brainstorm Cell Therapeutics Inc. entered into a Securities Purchase Agreement dated February 24, 2026, with an unidentified Purchaser to issue and sell unregistered securities pursuant to Section 4(a)(2) and Regulation D exemptions. Net proceeds are designated for working capital purposes, with covenants including share reservation, listing efforts on Trading Markets, and standard indemnification for the Purchaser. No specific pricing, share counts, or dilution impacts were disclosed in the agreement excerpt.

• ·SEC 8-K filed February 27, 2026, covering Items 1.01 (Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Director/Officer Changes), and 9.01 (Exhibits)
• ·Securities include Shares, Warrants, and Prefunded Warrant Shares
• ·Purchaser identity confidential except as required by law
• ·Prohibitions on use of proceeds for redemptions, litigation settlements, or FCPA/OFAC violations

27-02-2026

Ares Capital Corporation, acting as servicer and transferor for borrower Ares Capital JB Funding LLC, entered into Amendment No. 13 to its Loan and Servicing Agreement on February 25, 2026, increasing the maximum facility amount from $1.3B to $1.6B USD with lenders SMBC, Citizens Bank, N.A., and Sumitomo Mitsui Trust Bank, Limited, New York Branch. The amendment confirms no Events of Default, Unmatured Events of Default, or Servicer Termination Events are occurring. This expands borrowing capacity under the revolving credit facility originally dated January 20, 2012.

• ·Amendment effectiveness conditioned on payment of outstanding fees, delivery of executed signatures, opinions of counsel, and Borrower's payment of Administrative Agent's legal fees.
• ·Original Loan and Servicing Agreement dated January 20, 2012; prior amendments include No. 12 on July 25, 2025, No. 11 on December 6, 2024.

27-02-2026

ClearThink 1 Acquisition Corp., a blank check company targeting financial services, priced its $125M initial public offering of 12,500,000 units at $10.00 per unit, expected to list on NASDAQ under CTAAU starting February 24, 2026, with separate trading for shares (CTAA) and rights (CTAAR) thereafter. The offering, led by D. Boral Capital LLC, includes a 45-day over-allotment option for 1,875,000 additional units and is set to close on February 25, 2026, subject to customary conditions. No declines or flat metrics reported as this is an IPO pricing announcement.

• ·Registration statement effective February 13, 2026.
• ·U.S. counsel: Ruskin Moscou Faltischek, P.C.; Cayman counsel: Ogier (Cayman) LLP; Underwriters' counsel: Sichenzia Ross Ference Carmel LLP.
• ·SPAC focus: financial services sector in the United States and other developed countries.

27-02-2026

MOZAYYX Acquisition Corp., a blank check company, announced the pricing of its upsized initial public offering of 26,100,000 units at $10.00 per unit, raising $261M. Units are expected to list on the NYSE under 'MZYX.U' beginning February 25, 2026, with separate trading of Class A ordinary shares ('MZYX') and warrants ('MZYX.WS') thereafter. Cantor Fitzgerald & Co. served as sole book-running manager, with a 45-day underwriters' option for up to 3,915,000 additional units.

• ·Registration Statement on Form S-1 (333-293134) declared effective February 24, 2026.
• ·Company incorporated as exempted company under Cayman Islands laws, seeking merger or business combination.
• ·Press release dated February 24, 2026; SEC 8-K filed February 27, 2026.

27-02-2026

On February 26, 2026, Claire D’Oyly-Hughes Johnson resigned from the Board of Directors of Aurora Innovation, Inc., effective February 27, 2026, with no disagreements on operations, policies, or practices. Effective the same date, David Wehner, age 56 and Chief Strategy Officer at Meta Platforms, Inc. (formerly Facebook, Inc.), was appointed as a new director with a term expiring at the 2027 Annual Meeting of Stockholders. Mr. Wehner, with prior experience as CFO of Meta Platforms and Zynga Inc., is eligible for $60,000 in annual cash compensation plus equity awards under the Director Compensation Policy.

• ·David Wehner holds an M.S. in applied physics from Stanford University and a B.S. in chemistry from Georgetown University.
• ·No arrangements or understandings led to Mr. Wehner's appointment; no family relationships with other directors or officers.
• ·Company to enter standard indemnification agreement with Mr. Wehner.

27-02-2026

Coffee Holding Co., Inc. amended the Amended and Restated Employment Agreement of Executive Andrew Gordon, effective February 1, 2026, setting his annual base salary at $80,000 (potentially a reduction from prior levels). The amendment adds a $1.6M incentive bonus eligible for payment if Gordon remains employed until January 1, 2030, with full acceleration on termination without Cause or for Good Reason, and pro-rated for disability or death. No other financial performance metrics or period-over-period comparisons are provided.

• ·Incentive bonus payable within 74 days after January 1, 2030, if employed continuously from January 1, 2026.
• ·Full incentive bonus accelerates on termination without Cause or resignation for Good Reason, payable within 30 days without release requirement.
• ·Pro-rated bonus for disability or death based on full calendar quarters from January 1, 2026 (e.g., 8/16 quarters = 50%).
• ·Severance benefits require signed release within 21 days of termination, without imposing non-compete or confidentiality on Executive.
• ·Amendment signed February 2, 2026 (Gordon) and February 26, 2026 (Company), filed February 27, 2026.

27-02-2026

GE HealthCare Technologies Inc. entered into a 364-day revolving credit agreement dated February 26, 2026, providing a $500M revolving credit facility to enhance liquidity. JPMorgan Chase Bank, N.A. serves as administrative agent, with Citibank, N.A., BofA Securities, Inc., BNP Paribas Securities Corp., Goldman Sachs Bank USA, and Morgan Stanley Senior Funding, Inc. as joint bookrunners and lead arrangers. No performance metrics or comparisons are provided in the filing.

• ·Facility includes ABR Loans denominated in Dollars and Term Benchmark Borrowings in Agreed Currencies (Dollars, Euros, Sterling).
• ·Availability Period: from Closing Date to earlier of Final Maturity Date or termination of Commitments.

27-02-2026

Gentherm Incorporated and its subsidiaries entered into the First Amendment to the Second Amended and Restated Credit Agreement on February 24, 2026, amending provisions of the original June 10, 2022 agreement and adding a new Pari Passu Intercreditor Agreement exhibit. The amendment facilitates releases of certain borrowers and guarantors, including Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Licensing Limited Partnership (via mergers/dissolution), Gentherm Holding (Malta) Limited, Gentherm Automotive Systems (Malta) Limited (planned liquidation), and Gentherm Properties I, LLC (dissolved), with remaining obligations assumed by other loan parties. No changes to overall borrowing capacity or financial terms were specified.

• ·Original Credit Agreement dated June 10, 2022.
• ·Maltese Release letter agreement dated October 10, 2025.
• ·Administrative Agent to execute release documents at Company's expense.

27-02-2026

On February 26, 2026, Dipanjan Deb resigned as a member of the Board of Directors of GoodRx Holdings, Inc., effective immediately. Mr. Deb indicated that his decision was not due to any disagreement with the Company on matters relating to its operations, policies, or practices. The resignation was reported in an 8-K filing dated February 27, 2026.

27-02-2026

Binah Capital Group, Inc. amended the terms of its Series B Junior Convertible Preferred Stock via an Amended Certificate of Designation, allowing dividends payable in cash (with up to 50% in additional shares if no senior default under the Credit Agreement with Byline Bank exists). The Compensation Committee granted CEO Craig Gould 94,828 fully vested restricted shares of common stock valued at $220,000 and approved $350,000 annual incentive bonuses each for Gould and David Shane for FY 2025; it also amended Shane's employment agreement to extend the initial term to five years. No declines or flat performance noted in disclosed metrics.

• ·Series B Subscription Agreement dated September 4, 2024; original Certificate of Designation filed November 14, 2024
• ·Credit Agreement with Byline Bank dated December 23, 2024
• ·Executive employment agreements dated August 14, 2024 (Gould and Shane)
• ·Subordination agreement entered February 26, 2026
• ·Warrants exercisable at $11.50 per share

27-02-2026

HA Sustainable Infrastructure Capital, Inc. issued $600M aggregate principal amount of 7.125% Green Junior Subordinated Notes due 2056 on February 27, 2026, under an amended indenture with guarantees from several subsidiaries. Net proceeds will repay portions of revolving credit facility borrowings, commercial paper, or 8.00% Senior Notes due 2027, with ultimate allocation to eligible green projects within two years. The notes feature a fixed 7.125% rate until November 15, 2031, then reset at Five-year U.S. Treasury Rate plus 3.478% (floor 7.125%), but are junior subordinated with deferrable interest payments.

• ·Interest payments semi-annually on May 15 and November 15, commencing May 15, 2026.
• ·Notes subordinate to senior indebtedness and effectively junior to secured debt and subsidiary liabilities.
• ·Redemption options include 101% for Change of Control, 100% after specified dates or Tax Event, and 102% for Rating Agency Event.

27-02-2026

Whirlpool Corporation announced concurrent public offerings of common stock and depositary shares (each 1/20th interest in Series A Mandatory Convertible Preferred Stock), anticipating $800M in aggregate proceeds to repay revolving credit facility debt and fund general corporate purposes, including strategic investments in vertical integration and automation. The Preferred Stock carries a $1,000 liquidation preference per share and automatically converts into common stock around February 15, 2029. In 2025, Whirlpool reported approximately $16B in annual net sales (close to 90% in the Americas), 41,000 employees, and 35 manufacturing and technology research centers.

• ·Underwriters grant 30-day overallotment option for additional Common Stock and Depositary Shares.
• ·Depositary Shares to be listed on NYSE under symbol 'WHR.PRA'.
• ·Announcement dated February 23, 2026; automatic conversion of Preferred Stock on or about February 15, 2029.

27-02-2026

Ensysce Biosciences, Inc. received a Nasdaq deficiency notice on February 25, 2026, stating non-compliance with Listing Rule 5550(a)(2) as the common stock bid price closed below $1.00 for 30 consecutive business days. The company has 180 calendar days until August 24, 2026, to regain compliance by achieving a minimum bid price of $1.00 for at least 10 consecutive business days, with no immediate impact on trading under symbol ENSC. Failure to comply could lead to delisting, impairing liquidity, capital raising, and stock value.

• ·Company intends to monitor bid price and evaluate options like reverse stock split if needed
• ·Possible second 180-day compliance period if initial period fails and other standards met
• ·Delisting appeal possible to Nasdaq hearings panel, but no assurance of success

27-02-2026

Royal Caribbean Cruises Ltd. completed a $2.5B senior notes offering, consisting of $1.25B 4.750% Notes due 2033 and $1.25B 5.250% Notes due 2038, generating net proceeds of approximately $2.471B. The company intends to use the proceeds primarily to refinance senior notes maturing in 2026 and for repaying other existing indebtedness, including term loans. No performance declines or flat metrics are reported in this debt issuance filing.

• ·Underwriting agreement dated February 12, 2026.
• ·2033 Notes interest accrues at 4.750% per annum, payable semi-annually on May 15 and November 15, beginning November 15, 2026; matures May 15, 2033.
• ·2038 Notes interest accrues at 5.250% per annum, payable semi-annually on February 27 and August 27, beginning August 27, 2026; matures February 27, 2038.
• ·Issued pursuant to Base Indenture dated July 31, 2006, supplemented by Fifth Supplemental Indenture dated February 27, 2026.

27-02-2026

On February 25, 2026, affiliates of Amberjack Capital Partners, L.P. (Selling Stockholders) entered into an Underwriting Agreement with J.P. Morgan Securities LLC and others to sell 5,750,000 shares of Innovex International, Inc. (INVX) common stock at $25.75 per share, with the full 30-day option for 862,500 additional shares exercised, totaling 6,612,500 shares sold. The Company repurchased 575,000 of these shares from the Underwriters for approximately $14.1 million under its existing share repurchase program, leaving $76.6 million remaining in authorization; the Company received no proceeds from the stockholder sale.

• ·Underwriting Agreement dated February 25, 2026; Offering closed February 27, 2026
• ·Pursuant to effective S-3 shelf registration (File No. 333-282178, effective October 1, 2024)
• ·Share Repurchase approved by independent committee of the Board

27-02-2026

The Children’s Place, Inc. appointed Kim Roy, 67, as Executive Director and board member effective March 2, 2026, until the 2026 annual stockholder meeting. Ms. Roy has extensive experience leading multi-billion dollar brands at Ralph Lauren Corporation (Group President North America), Ann Taylor (President), Liz Claiborne, Inc. (Group President), and Associated Merchandising Corporation (SVP General Merchandise Manager). Compensation includes an annual base salary of $600,000, target performance bonus of 75% of base salary, and a sign-on award of 120,000 restricted stock units.

• ·Appointment announced February 23, 2026; employment on at-will basis
• ·No arrangement or understanding with any other person for the appointment
• ·Letter Agreement to be filed as exhibit to Form 10-K for fiscal year ended January 31, 2026

27-02-2026

Tenon Medical, Inc. received a Nasdaq notification letter on February 25, 2026, stating that its common stock (TNON) failed to maintain a minimum $1.00 closing bid price for 30 consecutive business days from January 9 to February 24, 2026, violating Listing Rule 5550(a)(2). The company has an initial 180-day compliance period until August 24, 2026, to achieve $1.00 for 10 consecutive business days, with potential for a second 180-day extension if other listing standards are met. While listing remains intact with no immediate delisting, failure to comply risks suspension and transfer from The Nasdaq Capital Market.

• ·Securities registered: Common Stock (TNON) and Warrants (TNONW) on Nasdaq.
• ·Company is an emerging growth company.
• ·Nasdaq requires public announcement under Listing Rule 5810(b).

27-02-2026

On February 27, 2026, Robert M. Williams, Jr. resigned as a Class I director of Aveanna Healthcare Holdings Inc. (AVAH), effective immediately, with no disagreement on the company's operations, policies, or practices. Prior to his resignation, Mr. Williams served on the Nominating and Corporate Governance Committee, the Compensation Committee, and the Clinical Quality and Compliance Committee. The filing was signed by Jeff Shaner, Chief Executive Officer.

• ·Company headquartered at 400 Interstate North Parkway SE, Atlanta, Georgia 30339.
• ·Registrant is a Delaware corporation with IRS Employer Identification No. 81-4717209 and Commission File Number 001-40362.

27-02-2026

Hashdex Nasdaq Crypto Index US ETF filed an 8-K disclosing Amendment #1 to its Authorized Participant Agreement with Virtu Americas LLC and sponsor Hashdex Asset Management Ltd., dated February 24, 2026. The amendment replaces the Procedures Handbook in full, updates the agreement summary, adds Section 16 for optional in-kind transactions using digital assets for Creation Unit creations/redemptions (minimum 10,000 Shares), and addresses regulatory changes, fees, taxes, and settlement procedures. No financial impacts or performance metrics are disclosed.

• ·Original Authorized Participant Agreement dated January 14, 2025.
• ·SEC Registration Statement No.: 333-280990.
• ·Purchase Order cut-off time: 3:00 P.M. Eastern.
• ·Standard settlement: T+1 business day following purchase order date.

27-02-2026

VERAXA Biotech AG shareholders approved the merger with Veraxa Biotech Holding AG and an ordinary capital increase of up to CHF 223,400 at their EGM on February 27, 2026, advancing the business combination with Voyager Acquisition Corp. (NASDAQ: VACH). The approvals are prerequisites for closing, subject to Voyager shareholder approval, after which the combined entity will trade on NASDAQ under 'VRXA'. No financial performance metrics or declines were reported, highlighting progress without disclosed setbacks.

• ·Business Combination Agreement signed on April 22, 2025.
• ·Proxy statement/prospectus filed with SEC on February 19, 2026.
• ·Merger via absorption: Veraxa Biotech Holding AG acquires VERAXA and renames to Veraxa Biotech AG.

27-02-2026

On February 24, 2026, Collin McQuiddy notified Enhabit, Inc. of his resignation as Senior Vice President and Chief Accounting Officer, effective March 27, 2026, to pursue another career opportunity, with no disagreements regarding company operations, policies, or practices. Ryan Solomon, the Company's Chief Financial Officer, will assume the functions of principal accounting officer on an interim basis without additional compensation or adjustments. Mr. Solomon has no family relationships with directors or executives and was not selected under any special arrangement.

• ·Filing date: February 27, 2026
• ·Date of earliest event reported: February 24, 2026
• ·Mr. McQuiddy will assist with transition through March 27, 2026
• ·Biographical information for Mr. Solomon available in 2025 Proxy Statement
• ·No related party transactions for Mr. Solomon under Item 404(a) of Regulation S-K

27-02-2026

Intuitive Machines, Inc. entered into a Registration Rights Agreement dated February 27, 2026, with investors party to a Securities Purchase Agreement dated February 25, 2026, providing for the registration of resale of Registrable Securities (shares issued thereunder). The Company is required to file a Registration Statement with the SEC no later than April 1, 2026, and use commercially reasonable efforts to have it effective within 30-60 days, maintaining effectiveness for up to five years from the Closing Date, subject to limited suspension periods. No financial metrics or performance data are disclosed in the agreement.

• ·Effectiveness targets: 30 days post-filing if no SEC review, 60 days if reviewed
• ·Allowed Delays: up to 45 consecutive days or 60 total calendar days in any one-year period, not more than two per year
• ·Effectiveness Period: until no Registrable Securities remain or fifth anniversary of Closing Date

27-02-2026

Energy Vault Holdings, Inc. issued an additional $10M in 5.250% Convertible Senior Notes due 2031 (Option Notes) to initial purchasers Jefferies LLC, Cantor Fitzgerald & Co., and Citigroup Global Markets Inc., bringing the total notes outstanding to $150M following the initial $140M issuance on February 17, 2026. The company entered into additional capped call transactions to reduce potential dilution upon conversion, with a cap price of $8.12 per share (100% premium over the February 11, 2026 closing price of $4.06). Proceeds from the initial notes were used to repay $45M in senior unsecured convertible debentures to YA II PN, Ltd. on February 19, 2026.

• ·Notes sold in transaction exempt from Securities Act registration requirements
• ·Additional Capped Call Transactions cover shares initially underlying the Option Notes, subject to customary adjustments
• ·Company does not intend to file registration statement for resale of Notes or shares issuable upon conversion
• ·Purchase Agreement dated February 11, 2026

27-02-2026

On February 25, 2026, Globe Life Inc.'s Board of Directors expanded from 12 to 14 members and appointed independent directors Derek T. Kan to the Audit Committee and Sandra L. Phillips to the Governance and Nominating Committee, with terms expiring at the April 30, 2026 Annual Meeting of Shareholders. Compensation follows the 2018 Non-Employee Director Compensation Plan, including prorated annual cash retainer of $110,000, equity retainer of $190,000, and $12,500 additional for Mr. Kan's Audit Committee role. There are no arrangements influencing their selection or disclosable transactions under Item 404(a) of Regulation S-K.

• ·Directors determined 'independent' per NYSE rules and Company criteria
• ·No understandings or arrangements pursuant to which Mr. Kan or Ms. Phillips were selected

27-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K/A on February 27, 2026, amending its February 25, 2026, 8-K to disclose a letter from Babak “Bob” Ghassemieh dated February 25, 2026, regarding his resignation from the Board of Directors, effective February 20, 2026. The filing includes the letter as Exhibit 17.1 under Item 9.01 and was signed by Jim Plohg, Executive Vice President, General Counsel & Secretary.

• ·Filing amends Original 8-K filed February 25, 2026
• ·Counsel for Mr. Ghassemieh submitted the letter in response to the Original Report

27-02-2026

iBio, Inc. entered into a new Open Market Sale Agreement (ATM Agreement) with Jefferies LLC on February 27, 2026, enabling at-the-market offerings of up to $100M in common stock pursuant to a new S-3 shelf registration (File No. 333-293864). This follows the termination on February 23, 2026, of a prior ATM Agreement dated July 3, 2024, with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC, which had an aggregate offering limit of $7.35M under S-3 File No. 333-280680. The new facility provides significantly expanded fundraising capacity compared to the prior smaller program.

• ·New ATM sales methods include at-the-market offerings on Nasdaq, block transactions, or privately negotiated transactions.
• ·Jefferies entitled to customary indemnification and no obligation to sell specific volumes.
• ·ATM terminates upon sale of all shares or as permitted by parties.

27-02-2026

WESCO Distribution, a wholly-owned subsidiary of WESCO International, completed a $1.5B senior notes offering on February 27, 2026, consisting of $650M 5.250% notes due April 15, 2031, and $850M 5.500% notes due April 15, 2034, issued at 100% of principal with net proceeds of approximately $1.48B. The proceeds will be used to redeem all outstanding 7.250% senior notes due 2028 on or after June 15, 2026, and repay a portion of the ABL Facility, effectively refinancing higher-rate debt at lower rates of 5.25-5.50%. No declines or flat metrics reported in this debt issuance event.

• ·Notes accrue interest semi-annually starting October 15, 2026, on April 15 and October 15.
• ·Issuer may redeem 5-Year Notes with make-whole premium prior to April 15, 2028, and up to 35% with equity proceeds; similar terms for 8-Year Notes prior to April 15, 2029.
• ·Change of control requires offer to repurchase at 101% of principal.
• ·Indenture covenants limit liens, restricted payments, sale-leasebacks, and mergers; some terminate upon investment grade ratings.

27-02-2026

Paramount Skydance Corporation (PSKY) will acquire Warner Bros. Discovery, Inc. (WBD) for $31.00 per share in cash, valuing WBD at $81B equity value and $110B enterprise value (7.5x fully synergized 2026 EBITDA), with over $6B in expected synergies from technology, efficiencies, and operations. The deal, unanimously approved by both boards, is funded by $47B in new Class B shares at $16.02/share from the Ellison Family and RedBird Capital Partners, plus $54B debt commitments, and is expected to close in Q3 2026 subject to regulatory and shareholder approvals. Strategic benefits include a combined film library of over 15,000 titles, commitment to 30 theatrical films annually, and enhanced DTC platforms like Paramount+, HBO Max, and Pluto.

• ·Shareholder vote expected in early spring 2026
• ·Conference call and webcast on March 2, 2026 at 8:30am ET
• ·Transaction terminates Paramount's prior all-cash tender offer for WBD
• ·Financial advisors: Centerview Partners LLC, RedBird Advisors (Paramount lead); Allen & Company, J.P. Morgan, Evercore (WBD)

27-02-2026

VisionWave Holdings, Inc. entered into a letter agreement dated February 26, 2026, with YA II PN, Ltd. to issue a $20M promissory note (net of 15% discount) and a warrant for 1,333,333 common shares exercisable for 5 years, under the existing SEPA with $49M remaining commitment after a prior $5M prepaid advance. The funding comes with strict covenants prohibiting related party payments, new indebtedness beyond permitted limits ($250k), variable rate transactions, and liens, while requiring subsidiary guaranties and future registration of warrant shares within 90 days of closing. This provides liquidity but introduces dilution risk and operational restrictions.

• ·SEPA originally dated July 25, 2025, amended January 19, 2025.
• ·Registration Statement for 10.2M SEPA shares declared effective February 17, 2026; no amendment required for new note or warrant shares.
• ·Warrant Registration Statement due within 90 days after Closing Date; demand registration within 45 days of notice.
• ·Prohibitions include prepayments to Evie Autonomous LTD and deferred underwriting commissions from Bannix Acquisition Corp. IPO.

27-02-2026

Blackstone Real Estate Income Trust, Inc. announced on February 26, 2026, the appointment of Paul Kolodziej as Chief Financial Officer and Treasurer, effective close of business on February 27, 2026, succeeding Anthony Marone who stepped down from those roles but will continue as Global Head of Real Estate Finance for Blackstone. Kolodziej, 46, has been a Managing Director with Blackstone Real Estate and previously served as the company's Deputy CFO from December 2023, Chief Accounting Officer from March 2019 to December 2023, and Controller from June 2016 to March 2019. No family relationships or reportable transactions under Item 404(a) of Regulation S-K exist with Kolodziej.

• ·Paul Kolodziej joined Blackstone in June 2016 after serving as Senior Manager at PricewaterhouseCoopers LLP, where he focused on real estate investment trusts and completed a two-year SEC Services Group rotation.
• ·Kolodziej holds a B.S. in Accountancy from DePaul University and is a Certified Public Accountant.

27-02-2026

On February 24, 2026, NextNav Inc.'s Board of Directors increased its size from 9 to 10 members and appointed Lisa Hook as a new director to fill the vacancy, naming her Lead Independent Director and a member of the Technology and National Defense Committee and Compensation and Human Capital Committees. Ms. Hook's compensation includes an initial equity grant of approximately $75,000, an annual equity grant of approximately $175,000, and an annual cash retainer of $80,000, plus standard committee fees. Her term expires at the 2026 Annual Meeting of Stockholders, where she will stand for reelection, and the Company will enter into a standard indemnity agreement with her.

• ·No arrangements or understandings exist between Ms. Hook and any other person regarding her appointment.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K involving Ms. Hook.
• ·Indemnity agreement with Ms. Hook to be substantially the same as for other directors (filed as Exhibit 10.2 to 8-K on October 28, 2021).

27-02-2026

Eastman Kodak Company entered into a new Executive Chairman and CEO Agreement with James V. Continenza, effective January 1, 2026, extending his employment term until December 31, 2030, replacing his prior agreement set to expire February 26, 2027. The agreement includes an annual base salary of $1.2M, annual cash incentive up to 125% of base salary ($1.5M max), a one-time renewal award of 5M RSUs vesting equally over five years starting December 31, 2026, and annual RSU awards valued at $2.5M (half time-vesting over three years, half performance-vesting). Termination provisions provide for two years' salary and incentive, accelerated vesting of certain RSUs, and 18 months of COBRA coverage if terminated without cause or for good reason.

• ·Mr. Continenza must provide 61 days' written notice before exercising certain stock options (February 2019 or July 2020 grants) if post-exercise ownership would exceed 4.99%.
• ·Full Employment Agreement to be filed as exhibit to Form 10-K for year ended December 31, 2025.

27-02-2026

Kinetic Seas Inc. (KSEZ) issued a $148,500 promissory note to Labrys Fund II, L.P. on February 23, 2026, for a $135,000 purchase price plus $13,500 OID and prepaid 8% interest of $11,880, maturing in 12 months. The note is convertible into common stock after 180 days at 85% of the lowest closing bid price over the prior 10 trading days, subject to a 4.99% beneficial ownership limit (adjustable to 9.99%). The company must reserve at least 10 million shares for potential conversions, posing dilution risk to existing shareholders.

• ·Default interest accrues at the lesser of 22% per annum or maximum permitted by law on overdue amounts.
• ·Holder may deduct $1,750 from each conversion amount to cover fees.
• ·Conversion rights begin 180 calendar days after Issue Date (approximately August 22, 2026).

27-02-2026

On February 25, 2026, CBRE Group, Inc. established new compensation targets for two named executive officers: Chad J. Doellinger (Chief Legal & Administrative Officer and Corporate Secretary) with a $700,000 base salary, $1.15M annual performance award target, and $2.75M total equity award target; and Daniel G. Queenan (Executive Group President, Trammell Crow Company) with a $700,000 base salary, $1.3M annual performance award target, and $3M total equity award target. Compensation targets for other named executive officers Robert E. Sulentic, Emma E. Giamartino, and Vikram Kohli remained unchanged.

• ·Filing submitted by Emma E. Giamartino on February 27, 2026
• ·CBRE Group, Inc. incorporated in Delaware, NYSE: CBRE, principal offices at 2121 North Pearl Street, Suite 300, Dallas, Texas 75201

27-02-2026

Healthcare Triangle, Inc. (Nasdaq: HCTI) announced definitive agreements for a registered direct offering of 681,553 shares of common stock (or prefunded warrants) at $5.81 per share, priced at-the-market under Nasdaq rules, expecting gross proceeds of approximately $3.959 million before fees. The closing is anticipated on or about February 27, 2026, with D. Boral Capital, LLC as sole placement agent. No period-over-period comparisons are provided, as this is a one-time financing event involving share dilution.

• ·Shelf registration statement on Form S-3 (File No. 333-276382) declared effective by SEC on January 31, 2024.
• ·Press release dated February 26, 2026; SEC 8-K filing dated February 27, 2026.
• ·Company based in Pleasanton, California.

27-02-2026

On February 24, 2026, Ambarella Inc.'s Compensation Committee approved the Fiscal Year 2027 Annual Bonus Plan (FY2027 Bonus Plan), featuring an aggregate target bonus pool approximately 28% larger than the FY2026 plan. CEO Feng-Ming Wang is eligible for a 100% bonus target of his base salary, with other executives (John Young, Chan Lee, John Ju, Yun-Lung Chen) ranging from 40% to 75%; payouts are weighted 1/3 each on revenue, operating profit, and non-financial objectives, with a maximum of 167% of target. No threshold performance results in zero funding, and payouts require continued employment.

• ·Compensation Committee and Board have discretion to adjust bonus pool size and individual payouts.
• ·Payouts to be made no later than two and one-half months after end of FY2027.
• ·Performance between threshold and target uses linear interpolation.

27-02-2026

Nuburu, Inc. amended its Amended and Restated Certificate of Incorporation to implement a reverse stock split, converting every 4.99 shares of Common Stock into one share, effective at 5:00 p.m. Eastern Time on February 27, 2026. The amendment, approved by the board of directors and stockholders, includes no changes to the number of authorized shares and rounds up fractional shares to full shares. This corporate action was filed with the Delaware Secretary of State on February 25, 2026.

• ·Filed with Delaware Division of Corporations at 05:00 PM on February 25, 2026 (SR 20260824506, File Number 7992745)
• ·No fractional shares issued; rounded up to full share

27-02-2026

Odyssey Marine Exploration Inc. entered into an Amended and Restated Joint Venture Agreement dated February 27, 2026, with Capital Latinoamericano (CapLat) and affiliates including Oceanica Resources, Oceánica Resources México (ORM), Phosagmex (JV entity), and Exploraciones Oceánicas (ExO) to advance a fertilizer production project extracting phosphate ore from Mexico's EEZ in the Gulf of Ulloa. The agreement amends the original December 23, 2024 JV agreement (amended June 5, 2025) and highlights progress such as JV entity formation, initial contributions, court-ordered reinstatement of mining concessions, exclusivity agreements with dredging and processing providers, substantial completion of the MIA application, and development of business plans. No financial metrics or declines reported.

• ·Concessions: 'Don Diego Reducción' (244813/240744), 'Don Diego Norte' (242994), 'Don Diego Sur' (242995)
• ·Original JV Agreement: December 23, 2024 (amended June 5, 2025)
• ·Assignment Agreement between ExO and Phosagmex: June 5, 2025
• ·Tax Assessment: Ruling Letter 500-36-07-03-01-2022-10636 dated September 8, 2022

27-02-2026

On February 27, 2026, Bridgewater Bancshares, Inc. and its subsidiary Bridgewater Bank entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $50 million of common stock through at-the-market offerings. The agreement allows sales via various methods, with the company paying a 2.5% commission on gross sales prices; there is no obligation to sell any shares, and either party may terminate at any time. Net proceeds, if any, will support general corporate purposes such as subsidiary investments, working capital, capital expenditures, stock repurchases, debt repayment, or acquisitions.

• ·Sales under the agreement will be made pursuant to shelf registration statement Form S-3 (No. 333-284662), effective February 10, 2025, with prospectus supplement filed February 27, 2026.
• ·Agreement includes customary representations, warranties, covenants, indemnification, and expense reimbursements.

27-02-2026

OpGen, Inc. (OTC: OPGN) announced its name change to CapForce Inc., effective February 27, 2026, to reflect a repositioning toward digital investment banking and fintech services targeting high-growth mid-sized companies with $1B-$10B market caps. The company plans to change its ticker to 'CFOR' and is developing a digital platform with AI-powered robo-advisory and cap table management, subject to market and regulatory factors; its controlling shareholder AEI Capital Group manages over $7B in AUM. Forward-looking statements highlight risks including rebranding costs, execution challenges, and potential customer/investor confusion.

• ·Name change effective February 27, 2026
• ·Expected ticker symbol change to 'CFOR'
• ·Subsidiaries: CapForce International Holdings Ltd. and iCapX Sdn. Bhd.
• ·AEI Capital Group footprints: Hong Kong, Kuala Lumpur, Singapore, London, Washington D.C.

27-02-2026

Pulse Biosciences, Inc. announced the immediate resignation of Kevin P. Danahy, its Chief Commercial Officer, effective February 27, 2026. The departure was not due to any disagreement with the company's operations, policies, practices, or accounting matters. The company recognized Mr. Danahy's contributions to senior management and early commercialization efforts.

• ·Resignation effective immediately
• ·No disagreement on operations, policies, practices, or accounting
• ·Company headquartered at 601 Brickell Key Drive, Suite 1080, Miami, Florida 33131

27-02-2026

American Healthcare REIT, Inc. entered into a new ATM Equity Offering Sales Agreement on February 27, 2026, for the offer and sale of up to $1.75B in common stock through multiple agents, terminating a prior ATM program from August 8, 2025, under which $230.1M remained unsold. Proceeds, if any, will be contributed to the Operating Partnership for general corporate purposes including debt repayment and investments. Sales depend on market conditions and company determinations, with agent commissions not exceeding 2.0%.

• ·Sales Agreement includes provisions for forward sale agreements with Forward Purchasers, allowing physical, cash, or net share settlement.
• ·Prospectus supplement dated February 27, 2026, under shelf registration Form S-3 (No. 333-281488) filed August 12, 2024.
• ·Legal opinion provided by Venable LLP (Exhibit 5.1).

27-02-2026

TRG Latin America Acquisitions Corp., a blank check company, priced its initial public offering of 20,000,000 units at $10.00 per unit, raising $200M, with units listing on Nasdaq under 'TRGSU' starting February 26, 2026. Santander serves as sole book-running manager and has a 45-day option to purchase up to 3,000,000 additional units for over-allotments. The offering is expected to close on February 27, 2026, subject to customary conditions.

• ·Units consist of one Class A ordinary share and one right for one-tenth of a Class A ordinary share upon business combination.
• ·Class A shares and rights to trade separately under 'TRGS' and 'TRGSR' no later than 52nd day after February 25, 2026.
• ·Registration statement effective February 25, 2026.
• ·Company is Cayman Islands exempted entity targeting business combinations, focusing on Latin America expertise.